TG Therapeutics | TGTX - Ebit

Prezzo Delle Azioni
30.36
Cambio Giornaliero
0.32 1.07%
Mensile
2.81%
Annuale
-27.52%
Q1 Previsione
27.12




Ebit Cambiamento Data
AbbVie USD 5.81B 4.36B 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.96B 464M 2025-12
Ardelyx USD 5.1M 2.02M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Biogen USD 659.6M 157M 2025-09
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Curis USD -12.37M 230K 2023-09
Gilead Sciences USD 2.96B 551M 2025-12
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
J&J USD 5.11B 2.3B 2025-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Novartis USD 4.06B 530M 2025-12
Novavax USD 20.94M 100.32M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12
Verastem USD -37.03M 6M 2024-09
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12